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Influenza A virus infections have been proposed to be associated with a broad spectrum of central nervous system
complications that range from acute encephalitis/encephalopathy to neuropsychiatric disorders in humans. In order
to study early influenza virus exposure in the brain, we created an influenza-infection model in neonatal mice to
investigate infection route and resulting pathological changes in the brain. Real-time polymerase chain reaction and
immunohistochemical analyses showed that influenza virus infection induced by an intraperitoneal injection was
first detected as early as 1 day post infection (dpi), and the peak infection was observed at 5 dpi. The viral antigen
was detected in a wide range of brain regions, including: the cerebral cortex, hippocampus, cerebellum, and
brainstem. Apoptotic cell death and gliosis were detected in the areas of viral infection. Significant increases in
proinflammatory cytokine expression were also observed at 5 dpi. Viral RNAs were detected in the cerebrospinal
fluid of infected adult mice as early as 1 dpi. In addition, many infected cells were observed near the ventricles,
indicating that the virus may enter the brain parenchyma through the ventricles. These results demonstrate that
influenza virus may effectively infect broad regions of the brain through the hematogenous route, potentially
through the cerebrospinal fluid along the ventricles, and subsequently induce neuropathological changes in the
neonatal mouse brain.Introduction
Highly pathogenic influenza A virus infection is a zoo-
nosis that results in high mortality in both animals and
humans. While influenza virus primarily targets the re-
spiratory system, it is capable of infecting the central
nervous system (CNS) in humans. Many clinical cases
with neurological symptoms in the human population
have been reported from 2009 influenza pandemic [1-4]
and from recent highly pathogenic influenza virus (H5N1)
infection cases [5-7].
Accumulating lines of evidence have shown that in-
fluenza virus infection can lead to diverse and pro-
longed neurological disturbances when the virus infects
the nervous system. One of the most interesting find-
ings is that a number of patients who recovered from
influenza virus infection during pandemics such as the
1918 Spanish flu developed neuropsychiatric disorders,
including: depression, schizophrenia, and Parkinsonism
[8]. Moreover, a report has shown that influenza virus* Correspondence: ssnahm@konkuk.ac.kr
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unless otherwise stated.is detected in the substantia nigra in many patients who
died from Parkinsonism [9], which provides a compelling
link between influenza infection in the brain and the
development of neurological disorders in humans. Re-
cently, additional scientific evidence derived using ani-
mal models suggests a direct relationship between
influenza virus infection and the occurrence of neuro-
logical disorders [10-12].
Several animal models have been used to study the
pathogenesis that is induced by influenza virus infection
[13,14]. Among them, mice and ferrets have been primar-
ily used to study influenza-associated neurologic disease
[13,15]. In addition, diverse inoculation methods, such as
intranasal, intraperitoneal, and intracranial injections, have
been employed to infect animals at different ages and for
research purposes [16-18]. In this study, we used an intra-
peritoneal infection method in neonatal mice to mimic
the hematogenous spread that results in systemic infection
[17,19]. Neonatal mouse models have been previously
used to study the impact of human infections during late
second/early third trimester of gestation on human brain
development [20].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sistent impairments in normal brain function [21-23].
Therefore, it is necessary to elucidate how influenza virus
infects the nervous system at an early age and what patho-
logical effects persist after infection. Previous reports using
animal models have shown that the hippocampus, sub-
stantia nigra, prefrontal cortex, and cerebellum, as well as
the paraventricular midline thalamic, medial habenular,
and hypothalamic nuclei, are the brain regions that are
affected after influenza virus infection [17-20]. Thus, we
generated an influenza-infection model system in neonatal
mice to study the neuropathological changes in the brain
in response to early influenza virus exposure at this critical
period.
Because elucidating the time course of infection and
the routes of virus invasion into the brain is important
for understanding the neuropathogenesis caused by in-
fluenza virus infection, several attempts have been made
to investigate the possible routes of viral entry into the
brain. To date, the suggested infection route of influenza
virus is mostly via transsynaptic transport through cra-
nial nerves, including the vagal and trigeminal nerves, in
mice [10,24-26]. Some other hypotheses have suggested
that the virus is disseminated through the blood circula-
tion [26-28] or through the olfactory nerves [10,11]. In
our study, we sought to decipher the neuropathological
changes that were caused by neonatal influenza infection
and to elucidate the infection route to the brain. To this
end, the temporal and spatial distribution of influenza
virus was examined, and the subsequent pathological
changes were determined. Lastly, the potential route of
influenza entry into the brain after intraperitoneal infec-
tion was investigated.
Materials and methods
Animal model and sample preparation
In order to determine the LD50 (lethal dose of 50%) of
influenza A virus infection in neonatal mice, 5-day-old
Balb/c mice with an average body weight of 2.6 g were
randomly assigned to each group (n = 10). Mice were in-
oculated intraperitoneally with 30 μL of mouse-adapted
neurotropic influenza A/NWS/33 virus (H1N1, ATCC
VR-219) propagated in specific pathogen-free embryo-
nated chicken eggs. Three concentrations of influenza A
virus (102, 103, or 104 TCID50/mL) were used. The mice
were observed daily for 3 weeks to determine the mor-
tality rate. LD50 was calculated by Miller and Tainter
method with minor modifications [29].
Once the LD50 was determined, the mice were intraperi-
toneally infected with a dose of 30 μL of 103 TCID50/mL
virus. Five-day-old Balb/c mice were infected with the
virus, sacrificed at 1, 2, 3, 4, 5, 7, 10, 15, and 21 days
post infection (dpi), and then compared to age-matched
control mice (n = 6/each dpi). The brains were collectedfrom each mouse and cut along the midsagittal plane.
Half of the brain sections were fixed in 10% neutral-
buffered formalin, and the rest were immediately stored
at −80 °C. The formalin-fixed brains were processed for
routine paraffin embedding, and the frozen brains were
used for RNA extraction.
The experimental protocols for the care and use of la-
boratory animals were approved by the Institutional Ani-
mal Care and Use Committee at Konkuk University
(Permit No.: KU13040). Throughout the protocols, all
efforts were made to minimize the number of animals
used and their suffering. All mice were kept under a
12 h light: 12 h dark cycle. Food and water were given
ad libitum up to the time of experiments. Animals were
monitored daily after influenza infection until sample
collection. During this study, humane endpoints were
used in accordance with Konkuk University standard op-
erating protocols. Mice that became cachectic or showed
signs of paralysis were euthanized before sample collec-
tion. For each time point, mice were anesthetized with
intraperitoneal injection of zoletil (90 mg/kg) and xyla-
zine (10 mg/kg) and euthanized by cervical dislocation
for sample collection according to standard protocols.
Real-time polymerase chain reactions for the
quantification of influenza A virus and proinflammatory
cytokines
Total RNA was extracted from each mouse brain (n = 6/
each dpi except n = 10 for 5 dpi) and from whole blood
with TRIzol reagent (Gibco, Life Technologies Corpor-
ation, Grand Island, NY, USA) according to the manu-
facturer’s instructions. cDNA was synthesized from 4 μg
of total RNA using oligo dT primers with a Prime-
Script™ II 1st strand cDNA Synthesis Kit (Takara Bio
Inc., Otsu, Japan). The Viral RNA in the whole brain
and blood was quantified by using M gene-based real-
time polymerase chain reactions (PCR) with a TaqMan
probe (QIAGEN Inc., Valencia, CA, USA), as previously
described [30]. Quantification of proinflammatory cyto-
kines (interleukin (IL)-1β, IL-6, and tumor necrosis factor
(TNF)-α) in the whole brain was performed with a SYBR
Premix Ex Taq™ II Kit (Takara Bio Inc.) in a CHROMO4™
(Bio-Rad Laboratories, Inc., Hercules, CA, USA) real-time
PCR system according to the manufacturer’s instructions,
with minor modifications. To control the variation in
the DNA amount available for PCR, the expression of
the target genes was normalized in relation to the ex-
pression of glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), which is an endogenous control. Each sam-
ple of the target and reference gene was run in duplicate
in separate wells. The PCR cycling conditions included
an initial step at 95 °C for 10 min, which was followed
by 40 cycles of 95 °C for 30 s, 55 °C for 30 s, and 72 °C for
30 s, and a final step at 72 °C for 5 min. The 2 - ΔΔCT
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gene expression [31]. The specific primer sequences for
the detection of influenza virus and proinflammatory cyto-
kines are shown in Table 1.
Histological techniques and immunohistochemical
staining procedures
To localize the infected virus in the brain (n = 3/each
dpi), serial 4-μm-thick sections were made from the
midsagittal plane, and every 20th section was stained for
influenza A virus. The sections were quenched with
0.3% H2O2 in methanol and subsequently blocked with
5% equine serum in phosphate-buffered saline (PBS) for
1 h at room temperature. The sections from control and
infected mice brains were incubated with the H1N1
influenza A virus antibody (10 μg/mL, Abd Serotec,
USA) overnight at 4 °C. The sections were then incu-
bated with biotinylated anti-goat IgG (3.75 μg/mL, Vec-
tor Laboratories, Inc., Burlingame, CA, USA) for 2 h at
room temperature and subsequently with horseradish
peroxidase-conjugated streptavidin (Vector Laboratories,
Inc.) for 1 h at room temperature. The virus was visualized
using diaminobenzidine as a substrate and counterstained
with methyl green. The stained slides were dehydrated,
mounted, and evaluated with a light microscope (Olympus
Corporation, Tokyo, Japan). Negative control staining was
carried out by omitting primary antibody incubation.
The locations of the infected virus were identified by
positive signal, and the intensity of the signal was de-
fined as follows: −, negative signal; +/−, weak signal;
and +, positive signal [32].
To evaluate the pathological changes caused by the
infection, brain sections were subjected to routine
hematoxylin and eosin (H&E) staining. In order to de-
tect glial cell activation and proliferation the sectionsTable 1 Sequence of primers and probe used in PCR
Sequence (5′ - 3′)
M F: AGA TGA GTC TTC TAA CCG AGG TCG
R: TGC AAA AAC ATC TTC AAG TCT CTG
P: FAM-TCA GGC CCC CTC AAA GCC GA-TAMRA
HA F: GAA AGC TCA TGG CCC AAC CA
R: TCC CAG GGG TGT TTG ACA CT
IL-1β F: GAC CTT CCA GGA TGA GGA CA
R: AGG CCA CAG GTA TTT TGT CG
IL-6 F: TAG TCC TTC CTA CCC CAA TTT CC
R: CAG TGA GGA ATG TCC ACA AAC TG
TNF-α F: CCG ATG GGT TGT ACC TTG TC
R: CGG ACT CCG CAA AGT CTA AG
GAPDH F: TTC ACC ATG GAG AAG GC
R: GGC ATG GAC TGT GGT CAT GAwere immunohistochemically stained with an antibody
to glial fibrillary acidic protein (GFAP; 5.8 μg/mL,
EMD Millipore Corporation, Billerica, MA, USA), which
is a specific marker for astrocytes, and an antibody to
ionized calcium-binding adapter protein 1 (iba1; 1 μg/mL,
Wako Pure Chemical Industries, Ltd., Osaka, Japan),
which is specific marker for the macrophage/microglia
lineage. The slides were incubated with the appropri-
ate secondary antibodies and horseradish peroxidase-
conjugated streptavidin and then processed as described
above.
Double-immunofluorescence staining was also carried
out to identify the types of cells that were infected with
influenza A virus. Deparaffinized brain sections were
stained for the H1N1 influenza A virus antibody
(10 μg/mL, Abd Serotec) and subsequently incubated
with a mouse monoclonal antibody to neuronal nuclei
(10 μg/mL, EMD Millipore Corporation), a rabbit poly-
clonal antibody to GFAP (5.8 μg/mL, EMD Millipore
Corporation), or a rabbit antibody to Iba1 (1 μg/mL,
Wako Pure Chemical Industries, Ltd.) for 4 h at 4 °C.
Then, the sections were incubated with a fluorescent
dye conjugated with anti-mouse IgG (DyLight™ 488,
Thermo Fisher Scientific Inc., Waltham, MA, USA) or
an anti-rabbit IgG (DyLight™ 405, Thermo Fisher Sci-
entific Inc.) for 2 h at room temperature. Subsequently,
the slides were mounted with Vectashield (Vector Labora-
tories, Inc.) and examined under an Olympus BX-51 fluor-
escence microscope (Olympus Corporation).
Analysis of cell death
A terminal deoxynucleotidyl transferase (TdT) dUTP
nick-end labeling (TUNEL) assay was performed in
deparaffinized tissue sections with an In Situ Cell Death
Detection Kit (Roche Diagnostics GmbH, Mannheim,
Germany) according to the manufacturer’s protocols.
Antigen retrieval was performed by heating the sections
in a microwave oven in 10 mM sodium citrate buffer,
pH 6.0, for 4 min. Thereafter, the sections were incubated
with TdT and fluorescein-labeled dNTP in Tris–HCl buf-
fer (30 mmol/L, pH 7.2) at 37 °C for 60 min. Incorporated
fluorescein was detected by an anti-fluorescein antibody
conjugated with horseradish peroxidase for 30 min at
37 °C. The slides were then incubated with diaminoben-
zidine for the signal conversion and counterstained with
methyl green. A negative control was performed by
omitting TdT, and mouse prostatic tissue was used as a
positive control for the TUNEL reaction.
Confirmation of apoptotic cell death
In order to determine if influenza infection evoked apop-
totic cell death, influenza-infected primary brain cell cul-
ture was treated with a pan-caspase inhibitor. The primary
brain cell culture was prepared from dissected mouse
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(Worthington Biochemical Corporation, Lakewood, NJ,
USA). All procedures were conducted according to the
manufacturer’s instructions with minor modifications.
Dissected cerebral cortex, brainstem, and cerebellum
were immediately incubated in a papain (20 U/mL) di-
gestion solution containing DNase I (0.005%, v/v) at
37 °C for 15 min. Then, the cells were dissociated by
gentle pipetting and subsequently centrifuged for 5 min
at 200 × g. The dissociation process was inhibited by an
ovomucoid protease inhibitor with bovine serum albu-
min and DNase I and finally centrifuged for 6 min at
100 × g. The cells were resuspended and plated on a
laminin-coated 6-well plate in Dulbecco’s Modified Eagle’s
Medium (DMEM) containing 10% fetal bovine serum
(FBS, Life Technologies Corporation) and penicillin-
streptomycin (100 units/mL; Sigma-Aldrich Co. LLC,
St. Louis, MO, USA). Cultured cells were maintained
at 37 °C in a humidified atmosphere with a 5% CO2
supplement.
The primary cultured cells were seeded in a 96-well
plate (105 cells/well) with 10% (v/v) FBS in DMEM.
The cultured cells were inoculated with influenza virus
at a dose of 107 TCID50/mL. After a 40-min incubation,
Z-VAD-FMK (20 μM, Promega Corporation, Madison,
WI, USA) was added with additional media to each well
in the pan-caspase-inhibitor-treatment group. To de-
termine the effects of the pan-caspase inhibitor on cell
viability after influenza infection, a neutral red uptake
assay was performed according to the protocols previ-
ously described [33]. Cell viability was measured by a
neutral red uptake assay at 12 h after infection. Neutral
red (40 μg/mL) was added to each well, and the cells
were incubated for 2 h at 37 °C. Then, the neutral red
medium was removed, and each well was washed with
PBS. Finally, the neutral red absorbed by viable cells
was extracted by Sorenson’s citrate buffer to measure
the total amount of neutral red at 540 nm.
CSF analysis in infected mouse brain
The cerebrospinal fluid (CSF) from infected mice was
collected according to the method of Liu and Duff [34].
Six-week-old Balb/c mice were used instead of 5–10-
day-old mice due to technical difficulties associated with
collecting adequate amount of CSF from neonates. The
mice were infected with influenza virus intraperitoneally
at a dose of 107 TCID50/mL. CSF samples from at least
3 mice were taken at 1, 2, 3, 4, and 5 dpi. The infected
mice were anesthetized with avertin and placed prone
on the stereotaxic instrument. A midsagittal incision of
the skin was made inferior to the occiput. Under the dis-
section microscope, the subcutaneous tissue and neck
muscles through the midline were bluntly separated with
microforceps. Then, the mouse was laid down so thatthe body made an approximately 135° angle with the
head. At this angle, the dura of the cisterna magna was
visible with a glistening reverse triangle, and a blood ves-
sel could be seen. The dura was carefully penetrated
with a pulled glass capillary (Borosilicate glass, B100-75-
10, World Precision Instruments, Inc., Sarasota, FL, USA)
that had a tapered tip with an inner diameter of 0.5 mm.
Following a perceptible change in the resistance to the ca-
pillary insertion, the CSF was collected into the capillary.
The average volume of the CSF obtained was approxi-
mately 2–4 μL. All samples were stored at −80 °C until the
PCR analysis. Conventional PCR was employed to amplify
virus from CSF directly due to extremely limited amount
of CSF collected from mouse brain. Repeated conventional
PCR of the CSF was performed with the primers specific
for influenza virus HA genes under the same condi-
tions. The amplified product, which was expected to
yield a 500-bp sequence, was analyzed by 1.5% agarose
gel electrophoresis. Further nucleotide sequencing was
performed by ABI Prism system (ABI 3730xl, Life Tech-
nologies Corporation).Statistics
All statistical analyses were performed with GraphPad
Prism version 5.0 (GraphPad Software, Inc., La Jolla, CA,
USA). The measured data were given as median except
mean ± standard error of the mean (SEM) for cell viability
tests in vitro. The differences in the cytokine analyses be-
tween the control and infection groups were examined
statistically with Mann–Whitney tests. Kruskal–Wallis
tests, which were followed by Dunn’s multiple comparison
tests, were used for both the cell viability tests in vitro and
virus quantification with real-time PCR in the brain.
Differences with p values less than 0.05 were considered
significant.Results
Determination of LD50 of influenza virus in neonatal mice
The influenza-infected mice were carefully observed daily
for their clinical symptoms and body weight changes for
3 weeks. While no mice died in the 102-TCID50/mL
group, the infected mice started to die from 4 dpi in the
103- and 104-TCID50/mL groups. In particular, mice that
were infected with 104-TCID50/mL of the influenza virus
showed 100% mortality within 6 dpi. However, the mice
infected with 103-TCID50/mL of the influenza virus con-
tinued to die until 9 dpi and showed a 50% survival rate
after 9 dpi. Thus, the LD50 of the A/NWS/33 virus in neo-
natal mice was determined to be 103 TCID50/mL by intra-
peritoneal injection. Mortality from influenza infection at
a dose of LD50 occurs primarily between 5 dpi and 6 dpi
(Figure 1).
Figure 1 Dose-dependent survival rates of intraperitoneal influenza virus infection in 5-day-old mice. Mice were infected with increasing
doses of the A/NWS/33 virus, and their survival rates were observed for 3 weeks. The LD50 of the A/NWS/33 virus in neonatal mice was determined to
be 103 TCID50/mL by intraperitoneal injection (n = 10/group).
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brain
To determine if the intraperitoneally infected influenza
virus could enter the brain, we tried to detect influenza
virus using PCR as well as immunohistochemistry. WeFigure 2 Influenza virus quantification in the infected brain. The quan
influenza virus infection as early as 1 dpi and a peak infection at 5 dpi. Vira
detected from 10 dpi to 21 dpi. Data were expressed as median (n = 6/dpi
or **, p < 0.01 or ***, p < 0.001 at 5 dpi; †, p < 0.05 at 7 dpi).first conducted real-time PCR to confirm the presence
of the influenza virus in the brain and the peak infection
time. The real-time PCR results showed that the influ-
enza virus infection took place as early as 1 dpi, and the
peak infection was observed at 5 dpi (Figure 2). At 5 dpi,titative real-time polymerase chain reaction (PCR) results showed
l infection was detected until 21 dpi, but only weak signal was
except n = 10 for 5 dpi; #, p < 0.05 or ##, p < 0.01 at 4 dpi; *, p < 0.05
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compared to those at the other sampling time points.
No viral M gene was detected in all blood samples
tested.
The real-time PCR and conventional PCR results
showed that the intraperitoneally infected influenza virus
could enter the brain. In order to confirm PCR results
and rule out blood contamination of the brain, we fur-
ther tried to localize influenza virus infected within the
brain parenchyma by using immunohistochemical tech-
niques. The immunohistochemical detection of influenza
virus showed that viral infection in the brain occurred as
early as 1 dpi and that the virus was detected until 5 dpi
(Table 2). Similar to the peak in the PCR results, the
peak viral infection was observed at 5 dpi. At 5 dpi,
many virus-infected cells were observed in multiple
brain regions, including i) the dentate gyrus, subiculum,
postsubiculum, and CA1 region of the hippocampal for-
mation, ii) Purkinje neurons, granule cells, and neurons
of the deep cerebellar nuclei in the cerebellum, iii) re-
ticular nucleus in the midbrain, iv) the caudoputamen
and globus pallidus, v) the olfactory bulb, anterior cingu-
late area, prelimbic area, somatomotor area, motor area,
and retrosplenial area of the cerebral cortex, vi) the pon-
tine reticular nucleus and tegmental reticular nucleus in
the pons, vii) the dorsal thalamus in the diencephalon,
viii) the nucleus raphe magnus and nucleus rapheTable 2 Immunohistochemical distribution of viral antigen in
Dpi* No.** Localiza
Cerebral cortex Hippocampus Diencephal
1 1 - - -
2 - - +
3 - - -
2 1 +/− - -
2 +/− - -
3 - - -
3 1 - - -
2 - - -
3 - - -
4 1 - - -
2 + - +
3 + - +
5 1 + + +
2 + - +
3 + - +
7 1 - - -
2 - - -
3 - - -
The temporal and spatial localization of virus was evaluated by the presence and in
(*: Days post infection; **: n = 3/days post-infection; ***: −, negative signal; +/−. weaobscurus in the medulla oblongata and ix) ventricular
ependymal cells, as well as choroid plexus epithelial cells
(Figure 3, Table 2). It should be noted that the viral anti-
gen that was detected near the periventricular region ex-
hibited a unique pattern with a gradual increase. In this
area, more infected cells were detected close to the ven-
tricle, while less infected cells were observed away from
the ventricle (Figure 3E). Control staining was carried out
to validate specificity of the antibody against influenza
virus by omitting primary antibody for staining infected
mouse brain sections or in specific pathogen free (SPF)
mouse brain sections. No viral antigen was detected in
infected brains stained without primary antibody or SPF
mouse brains (Figure 3F and 3G).
To determine the types of infected cells, double-
immunofluorescence staining was performed either with
influenza virus and a neuronal marker (NeuN) or with in-
fluenza virus and an astrocyte marker (GFAP). The results
revealed that influenza virus could infect both neurons
and astrocytes (Figure 3H and 3I).
Histopathological assessment of the infected brain
In order to investigate the histopathological changes in
the influenza-infected brain, H&E-stained sections were
examined at 1, 2, 3, 4, 5, 7, 10, 15, and 21 dpi. Surprisingly,
we were not able to detect any dramatic histopatho-
logical changes in most of the sections examined. Theinfected mouse brain
tion of viral antigens***
on Midbrain Pons Medulla oblongata Cerebellum
+ + + -
+ - + -
+ + + -
- - - +/−
- - + +/−
- + + +/−
- - + +
- - +/− +/−
- - +/− +/−
- - - +/−
- - + +/−
+ + + +
+ - - -
+ + + +
+ + + +
- - - -
- - - -
- - - -
tensity. No viral antigen was detected at 10, 15, and 21 dpi (data not shown).
k signal; +, positive signal).
Figure 3 Immunohistochemical detection of intraperitoneally infected influenza virus in the brain. Influenza virus was detected in the
hippocampus (A), the cerebellum (B, inset shows infected Purkinje cells), the thalamus (C), choroid plexus of fourth ventricle (D), and the
periventricular region (E) of infected mouse brain at 5 dpi. No viral antigen was detected in the infected mouse brain stained without primary
antibody (F) and the thalamus of SPF mouse brain (G). Double-immunofluorescence staining for influenza virus (red, H-I) and neuronal marker
(NeuN, green, H) or astrocyte marker (GFAP, green, I) show either virus-infected neurons or astrocytes. Scale bar for A-D, G = 100 μm; for E-F= 200 μm;
for H-I = 25 μm.
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trophil infiltration and neuronophagia in the cerebral
cortex at 5 dpi (data not shown). However, subsequent
immunohistochemical staining for microglia and astro-
cytes showed that both types of glial cells were markedly
activated and had proliferated, particularly at 5 dpi,
when compared to control mouse brain (Figure 4A and
4D).
Apoptotic cell death caused by neonatal influenza
infection
As the H&E-stained brain sections showed the presence
of some cells undergoing degenerative changes, we
sought to determine the mode of cell death that wascaused by the influenza infection. A TUNEL assay in
the infected brain revealed that many of the cells were
undergoing apoptotic cell death in various brain regions
at 5 dpi (Figure 5A). To confirm that influenza infection
caused apoptotic cell death, a pan-caspase inhibitor was
added to the primary neuron/glia-mixed culture simul-
taneously with influenza virus inoculation in vitro. The
pan-caspase inhibitor treatment resulted in a significant
increase in viable cells (Figure 5D). In particular, the via-
bility of the cells that were prepared from the cerebral cor-
tex reached nearly 95% with the pan-caspase inhibitor
treatment. In contrast, the viability of the cells prepared
from the cerebellum and brainstem was increased, but it
was still significantly lower than the viability of the control
Figure 4 Glial activation of the influenza-infected brain. Immunohistochemical staining of microglia (A, C) and astrocytes (B, D) in the
hippocampus of infected mice at 5 dpi with age-matched control mice. Note that many glial cells with activated morphology are seen in the
infected mice brain (A, B), whereas resting glial cells are stained in control mouse brain (C, D). Scale bar = 50 μm.
Figure 5 Apoptotic cell death caused by neonatal influenza infection. (A) A representative image of a terminal deoxynucleotidyl transferase
dUTP nick-end labeling (TUNEL) assay in virus-infected brain shows many TUNEL-positive cells in the thalamus, which indicates cells degenerating
by apoptosis. Double-immunofluorescence staining for TUNEL (Red, B-C) and the neuronal marker (NeuN, green, B) or astrocyte marker (GFAP,
green, C) show either neurons or astrocytes undergoing apoptotic cell death (arrows in B, C). Scale bar for A = 100 μm; for B = 50 μm; for
C = 25 μm. (D) Comparison of cell viability with pan-caspase inhibitor treatment in influenza-infected primary brain cell culture. Primary cultured
neuronal cells (105 cells/well) were treated with a Z-VAD-FMK inhibitor (20 μM) after virus inoculation. Statistical analysis of the three groups
shows a significant increase in cell viability with pan-caspase inhibitor treatment. The different numbers above the bars indicate significant
statistical difference (Dunn’s multiple comparison test, mean ± SEM, p < 0.0001).
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http://www.veterinaryresearch.org/content/45/1/63culture. Double-immunofluorescence staining showed that
both neurons and astrocytes were infected by influenza in-
oculation and that both types of cells underwent apoptotic
cell death (Figure 5B and 5C).Changes in proinflammatory cytokine expression in the
infected brain
To assess the immune responses of the brain against in-
fluenza virus infection, changes in proinflammatory cy-
tokines, which are known to induce inflammation, were
investigated. The temporal changes in TNF-α, IL-6, and
IL-1β mRNA expression were analyzed by quantitative
real-time PCR at 1, 2, 3, 4, 5, 7, 10, 15, and 21 dpi. The
mRNA levels of TNF-α, IL-6, and IL-1β showed a
marked increase at 5 dpi, and they then returned to the
baseline levels at 10 dpi. There was a similar temporal
trend in the expression of the 3 cytokines in the infected
brain, and all cytokines showed a statistically significant
difference at 5 dpi (Figure 6).Influenza virus detection in the CSF from infected brain
One of the most important findings of the distribution
of the virus in the brain was the gradual increase in the
occurrence of virus-infected cells near the ventricle
(Figure 3E). This finding suggested that the virus may
enter the brain through the ventricle. Thus, we tried to
detect the virus in the CSF of infected mice. PCR analysis
showed the presence of influenza virus as early as 1 dpi,
and it continued to be detected until 5 dpi (Figure 7). The
final amplified PCR products were further validated by se-
quencing. Sequence comparisons of the amplified product
and the HA gene confirmed that influenza was present in
the CSF. This result indicated that the CSF might contrib-
ute to influenza infection in the brain.Figure 6 Real-time polymerase chain reaction analysis of proinflamm
All data were normalized against the levels of glyceraldehyde 3-phosphate
factor (TNF)-α (A), interleukin (IL)-6 (B), and IL-1β (C) all show a similar tem
control brain. Data were expressed as median (n = 6/dpi except n = 10 forDiscussion
To the best of our knowledge, observation of patho-
logical changes of influenza-infected neonatal mouse in
time-dependent manner has not been reported. Our
study showed that intraperitoneally injected influenza
virus could enter the neonatal mouse brain and induced
brain cell death, which eventually resulted in neuroin-
flammation. The value of our study is the demonstra-
tion of the temporal and spatial localization of influenza
virus in the brain caused by intraperitoneal infection
and to provide potential infection routes of influenza
virus in the brain. Although neuropathogenesis has
been well described for intranasal influenza inoculation
in adult animals [12,24,25,35], few studies have been
carried out to investigate neuropathological changes after
neonatal infection. Therefore, we chose to use an intraper-
itoneal inoculation method with mouse-adapted neuro-
tropic influenza A virus (A/NWS/33) to elucidate the
neuropathologies caused by neonatal infection.
A previous study has reported the temporal localization
of influenza virus after intranasal inoculation [10,36]. Park
et al. [10] reported that the intranasally inoculated highly
pathogenic avian influenza virus was observed in the nasal
mucosa beginning at 1 dpi. According to their findings,
the viral antigens were first detected in the brainstem at 4
dpi, and it was not until 5 dpi that viral antigens became
widely distributed throughout a variety of brain regions. In
addition, Majde et al. [36] have demonstrated that mouse-
adapted non-neurotropic human influenza viral antigens
were detected in mouse olfactory bulb within the first
15 h after intranasal infection. Although their results and
our findings were not directly comparable because the
viral virulence and infection methods were different, it is
quite interesting to note that the rate of viral spread in the
brain was quite comparable regardless of the differences
in viral virulence and infection routes.atory cytokine expression in the influenza-infected mouse brain.
dehydrogenase (GAPDH) expression. The levels of tumor necrosis
poral change in that mRNA expression at 5 dpi was higher than that in
5 dpi; *, p < 0.05; **, p < 0.01; ***, p < 0.001).
Figure 7 Detection of virus RNA in the cerebrospinal fluid (CSF) of infected mice. A representative image of a gel electrophoresis analysis
of the HA gene sequence that was amplified from the CSF. The virus was detected in the CSF of mice from 1 dpi to 5 dpi.
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http://www.veterinaryresearch.org/content/45/1/63In our study, the virus-infected brain regions were the
hippocampus, the cerebellum, the brainstem, the stri-
atum, the cerebral cortex, as well as the periventricular
regions including the ventricular ependymal cells and
choroid plexus epithelial cells, which were in part coinci-
dent with the distributions of the virus in the mouse
brain that have been described [10,25]. Iwasaki et al. [25]
have described virus-infected brain areas, which were
consistent with the findings of our studies. However,
Park et al. [10] and Matsuda et al. [37] have reported
that virus-infected cells were observed in the nucleus of
the solitary tract and nucleus ambiguous in the brainstem.
We were not able to detect influenza virus in those areas.
On the other hand, highly pathogenic influenza virus was
identified in the cerebral cortex, the brainstem, the cere-
bellar Purkinje cells, the internal capsule, and the adjacent
thalamus in ferret brains [38]. In particular, Yamada et al.
[35] have described that influenza virus was observed in
the ependymal cells lining the ventricles and in the chor-
oid plexus epithelial cells, but not in any of the endothelial
cells of the blood vessels in the ferret brain, which was in
accordance with our findings. Such discrepancies in the
virus distribution from various studies may be attributable
to the animal species, the virus strains, and the inoculation
routes that are used in the studies.
We found that many neurons and astrocytes had
degenerated via apoptosis in the virus-infected regions,
and this may result in permanent brain dysfunction if the
infection occurred during the period of brain maturation.
Apoptosis is known to be involved in various neurological
disorders, including virus-induced CNS diseases [39]. It
has been reported that influenza virus induces apoptotic
neuronal death in the anterior olfactory nucleus of mice
[40] and cultured primary cells [41]. Interestingly, we ob-
served that the increase in cell viability induced by the
pan-caspase inhibitor treatment was different across brain
areas. In particular, the cell death caused by influenza in-
fection in the cerebellum and brainstem was not inhibited
to the same degree as in the cerebrum. These results sug-
gest that other cell death mechanisms might contribute to
cell death in these brain regions. However, no direct evi-
dence of other cell death pathways has been presented
until now. In addition, we observed severe gliosis, which
was possibly due to neuronal death in the infected brain.
These findings support previous reports suggesting that
influenza A virus induces severe neuroinflammation in the
brain accompanied by gliosis [24,42,43].There have been a number of previous studies on the
infection routes of influenza virus into the CNS after
intranasal inoculation. Currently, it has been proposed
that influenza virus reaches the CNS primarily though
the cranial nerves [10,24,37,44] or the peripheral nerves
[10]. It has also been suggested that the olfactory pathway
is an additional minor infection route to the brain in mice
[10], as well as a major infection route to the brain in in-
fected ferrets [11,35]. Furthermore, hematogenous spread
by breakdown of the blood–brain barrier (BBB) has been
suggested as the infection route of influenza virus to the
brain [45]. Virus invasion through hematogenous routes
implies that the virus could cross either the BBB in the
vascular endothelium of the brain or the blood-CSF bar-
rier that is restricted to the epithelial cells of the choroid
plexus in the ventricular system [46].
Based on our results, influenza infection through the
cranial nerves alone does not seem to fully explain the
virus distribution in the neonatal mouse brain because
the brain lesions caused by influenza virus were widely
distributed throughout the brain, and the virus antigen
was not prominently stained in the nuclei that are associ-
ated with cranial nerves. Previous studies have shown that
the levels of proinflammatory cytokines including TNF-α,
IL-6, and IL-1β are increased at day 6 or 7 after influenza
A virus infection [42,45]. In addition, it has been suggested
that an influenza infection-induced cytokine storm could
lead to vascular hyperpermeability [45]. Therefore, we ini-
tially considered that a hematogenous spread caused by
BBB dysfunction might be an additional infection route to
the brain. Similar to the findings of previous studies, our
data showed that proinflammatory cytokine expression
was markedly increased near 5 dpi. Interestingly, IL-6 ex-
pression levels of control brains appeared to be higher
than those of infected brains at 15 dpi and 21 dpi. The
reasons for this phenomenon are still unclear, because lit-
tle information is available for changes in IL-6 expression
at this age in control mice. It has been suggested that the
presence of influenza virus receptors and the detection of
viral antigens in endothelial cells in the brain parenchyma
could support hematogenous viral spread to the brain
[27,28]. However, we did not observe that endothelial cells
were infected with influenza virus, while no viral RNA was
detected in blood by real-time PCR in our study (data not
shown).
The possibility of influenza virus entry into the brain via
CSF by crossing the blood-CSF barrier has been suggested
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http://www.veterinaryresearch.org/content/45/1/63in ferrets [35] and chickens [28]. They have reported that
the virus was found in CSF from infected animals. Either
ependymal cells in the ventricle or choroid plexus epithe-
lial cells were positive for viral antigen [28,35]. Although
we detected viral RNA in the CSF using adult mice instead
of using neonates, it is possible that CSF plays important
roles in influenza infection to the brain of neonatal mice.
In addition, there are some clinical cases that influenza
virus was detected in CSF in human cases of influenza-
associated encephalitis/encephalopathy [5,47-49].
Yet there has been no direct evidence of influenza
virus entry into the brain through the CSF in mice.
Thus, we tried to detect influenza virus in the CSF of
infected mice to show that influenza virus could enter
the brain through the ventricles. The BBB begins to form
between E11 - E17 in the mouse and tight junctions are
present at that period. Thus, the movement of macromol-
ecules is restricted [50,51], indicating the BBB permeability
of neonates seems to be similar to that of adult mice.
We found that the virus RNA was detected in the CSF
of infected adult mice from 1 dpi to 5 dpi, and this was
in accordance with virus detection near the periven-
tricular region and ventricular ependymal cells. Proving
the routes of influenza virus infection into the brain was
the most challenging experiment in our study. Taken to-
gether, virus localization near the ventricle and the pres-
ence of viral RNA in the CSF provide quite persuasive
evidence that the ventricles and CSF are important con-
duits of influenza virus to the brain.
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